ArticleFrontiers in pharmacology2021

Association of EGFR Tyrosine Kinase Inhibitor Treatment With Progression-Free Survival Among Taiwanese Patients With Advanced Lung Adenocarcinoma and EGFR Mutation.

Po-Yen Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.